Seth Baum
Cardiovascular Disease · Boca Raton, FLNPI 1649210121
Payments from drug & device makers
Across 1,725 payments — averaging $6414.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$4.4M
- Amgen$1.4M
- Novartis$1.2M
- Regeneron$859K
- AstraZeneca$734K
- Novo Nordisk AS$577K
- plus $1.9M from 24 others
Across 40 payments — averaging $2533.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$53K
- Regeneron$40K
- Amgen$6K
- Novartis$3K
- Novo Nordisk AS$50
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 135 | $4,426,283 |
| Amgen | 147 | $1,363,710 |
| Novartis | 57 | $1,178,783 |
| Regeneron | 332 | $859,325 |
| AstraZeneca(2 entities) | 12 | $733,572 |
| Novo Nordisk AS | 435 | $576,718 |
| Genentech, Inc. | 28 | $428,781 |
| Akcea Therapeutics, Inc. | 27 | $250,782 |
| Janssen Research & Development, LLC | 13 | $207,556 |
| Merck | 15 | $158,747 |
| Boehringer Ingelheim | 40 | $142,832 |
| Pfizer | 15 | $114,365 |
| Madrigal Pharmaceuticals | 58 | $111,731 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 19 | $93,017 |
| Boehringer Ingelheim International GmbH | 163 | $82,595 |
| Esperion Therapeutics, Inc. | 73 | $61,046 |
| Ionis Pharmaceuticals, Inc. | 26 | $55,752 |
| Kaneka Medical America LLC | 3 | $44,754 |
| Alnylam Pharmaceuticals Inc. | 31 | $42,562 |
| Regeneron Healthcare Solutions, Inc. | 23 | $31,730 |
| Astrazeneca UK Limited | 2 | $24,239 |
| Lilly USA, LLC | 29 | $20,380 |
| E.r. Squibb & Sons, L.L.C. | 11 | $12,877 |
| Novo Nordisk | 10 | $12,730 |
| Sanofi US Services Inc. | 3 | $11,968 |
| Acerus Pharmaceuticals Corporation | 3 | $8,204 |
| AbbVie | 1 | $6,338 |
| Amryt Pharma Holdings Ltd | 12 | $3,179 |
| Boston Scientific | 1 | $133 |
| Echosens North America, Inc. | 1 | $41 |
How this compares
$11,064,730 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Boca Raton
- David FuntBoca Raton$2.8M
- Michael KorenGainesville$31M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.